---
title: Esco Aster vs uBriGene
slug_a: escoaster
slug_b: ubrigene
site: cdmo
review_signal_gate: closed
canonical_path: /compare/escoaster/ubrigene
generated_by: BioBM Editorial AI
---

# Esco Aster vs uBriGene

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Esco Aster (escoaster) is listed for both. Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.

Services: 5. Modalities: 4. Indications: 4. Locations: 0. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

uBriGene (ubrigene) is listed for both. uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.